Validated by over 8,000 surgeries across nearly 200 medical institutions and 1,000+ surgeons
our robust robotic system received NMPA approval for four departments in December 2022 and EU CE certification in January 2025, enabling global reach.
• Mature and Reliable Product
The Edge® Multi-Port Robot has demonstrated exceptional performance across 6,000 clinical cases, covering Grade IV highly complex surgeries in urology, gynecology, general surgery, and thoracic surgery.
• World-Class Performance
Outstanding fluency, ultra-high-definition imaging with true-to-life color, ultra-low master-slave latency, and ergonomic design ensure precise and seamless operation.
• Global Surgical Connectivity
Seamlessly compatible with tele-surgery systems, integrating 5G, dedicated lines, and broadband networks for stable signals and ultra-low latency. Successfully supports domestic and international remote surgery livestreams.
• Compatible and Interchangeable Platform
Shares a unified surgeon console and imaging system with the Single-Port Robot, enabling smooth switching between multi-port and single-port procedures to enhance surgical collaboration efficiency.
Edge Medical, a pioneering Chinese medical robotics company, has developed a comprehensive suite of minimally invasive surgical robots. Notably, Edge Medical is the first company in China to complete pivotal clinical trials for both multi-port and single-port endoscopic surgical robots, and stands among the few globally to offer a bronchoscopic surgical robot.
Surgripharma is proud to join hands with Edge Medical as their Sole Representative in Sri Lanka, to promote and support the full range of Edge Medical’s advanced robotic surgical platforms. This partnership marks a significant step forward in bringing cutting-edge robotic-assisted surgical technologies to the healthcare sector in Sri Lanka.
